{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:18:01Z","timestamp":1773717481076,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003190.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T00:00:00Z","timestamp":1192579200000}}],"reference-count":67,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003190.pub4","type":"journal-article","created":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T12:19:30Z","timestamp":1192018770000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Anticholinergic drugs versus other medications for overactive bladder syndrome in adults"],"prefix":"10.1002","volume":"2009","author":[{"given":"Campbell","family":"Roxburgh","sequence":"first","affiliation":[{"name":"Glasgow Royal Infirmary; 2nd Floor Queen Elizabeth Building; Alexandra Parade Glasgow UK G31 2ER"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Cook","sequence":"additional","affiliation":[{"name":"University of Aberdeen; Health Services Research Unit; 3rd Floor Health Sciences Building Foresterhill Aberdeen Scotland UK AB25 2ZD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman","family":"Dublin","sequence":"additional","affiliation":[{"name":"University Malaya Medical Centre; Division of Urology, Department of Surgery; 59100 Kuala Lumpur Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,10,17]]},"reference":[{"key":"10.1002\/14651858.CD003190.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-5347(17)56251-5","article-title":"An objective comparison of the effects of parenterally administered drugs in patients suffering from detrusor instability","volume":"122","author":"Cardozo","year":"1979","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-2008-1026333","article-title":"Comparison of emepronium bromide with intravesical administration of lidocaine gel in women with urge incontinance","volume":"51(1)","author":"Enzelsberger","year":"1991","journal-title":"Geburtschilfe und Frauenheilkunde"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0003|cit3","first-page":"486","article-title":"Intravesical instillation of trospium chloride, oxybutinin and verapamil for relaxation of the bladder detrusor muscle. A placebo contolled randomized clinical test.","volume":"48(5)","author":"Frohlich","year":"1998","journal-title":"Arzneimittelforschung"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000280298","article-title":"Motor urge incontinence: diagnosis and treatment","volume":"35(1)","author":"Gaudenz","year":"1980","journal-title":"Urologia Internationalis"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0005|cit5","first-page":"65","article-title":"Double blind comparison of flavoxate and propantheline as urologic antispasmodics","volume":"1","author":"Herbst","year":"1970","journal-title":"American Journal of Clinical Research"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1464-410X.1983.tb07075.x","article-title":"Placebo - the drug of choice in female motor urge incontinence?","volume":"55(1)","author":"Meyhoff","year":"1983","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00372799","article-title":"Double blind crossover comparison of flavoxate and oxybutynin in women affected by urinary urge syndrome","volume":"4","author":"Milani","year":"1993","journal-title":"International Urogynaecology Journal"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0008|cit8","unstructured":"Riva D Vigano R Azzolini E Colli E Sartanj A Scatigna M A randomised, double-blind, crossover trial on the effecacy and tolerance of falvoxate and oxybutynin in the treatment of urge incontinence Proceedings of the International Continence Society (ICS), 13th Annual Meeting; 1989 Sept 7-9; Ljubljiana, Slovenia 1989 218"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1520-6777(1998)17:1<31::AID-NAU6>3.0.CO;2-E","article-title":"Prospective study comparing hyoscyamine, doxazosin and combination therapy for the treatment of urgency and frequency in women","volume":"17(1)","author":"Serels","year":"1998","journal-title":"Neurourology & Urodynamics"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-5347(17)60271-4","article-title":"A comparison of emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence","volume":"110(5)","author":"Stanton","year":"1973","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0011|cit11","first-page":"248","article-title":"Clinical evaluation of propiverine hydrochloride (P-4) for the treatment of urinary frequency - A double-blind controlled study using flavoxate hydrochloide","volume":"52(2)","author":"Takayasu","year":"1990","journal-title":"Nishinihon Journal of Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0012|cit12","first-page":"259","article-title":"Comparative studies of the effect of mictonorm (propiverin hydrochloride) and Spasuret (flavoxate hydrochloride) on the bladder detrusor muscle (GERMAN)","volume":"82(5)","author":"Wehnert","year":"1989","journal-title":"Zeitschrift Fur Urologie und Nephrologie"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000280889","article-title":"A comparision between the combination emepronium bromide\/flavoxate and emepronium bromide in the treatment of detrusor instability","volume":"38(3)","author":"Aagaard","year":"1983","journal-title":"Urologia Internationalis"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1464-410X.1988.tb13964.x","article-title":"Terodiline, Emepronium bromide or placebo for treatment of female detrusor overactivity? A randomized, double -blind cross-over study","volume":"61(4)","author":"Andersen","year":"1988","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0015|cit15","first-page":"308","article-title":"Combination treatment with an a-blocker plus an anticholinergic improves quality of life in patients with bladder outflet obstruction. A prospective, randomized, controlled study (Abstract)","volume":"21(4)","author":"Athanasopoulos","year":"2002","journal-title":"Neurourology and Urodynamics"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0016|cit16","unstructured":"Barnick CGW Cutner A Cardozo LD Detrusor instability: a double blind, dose titrated, cross-over study of Oxybutinin vesus Terodiline Proceedings of the International Continence Society (ICS), 21st Annual Meeting; 1991 Oct 10-12; Hannover, Federal Republic of Germany 1991 181 2"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1532-5415.1985.tb02856.x","article-title":"The effects of terodiline and melardazine on sever motor urge incontinence in geriatric patients","volume":"33(1)","author":"Beisland","year":"1985","journal-title":"Journal of American Geriatric Society"},{"issue":"1","key":"10.1002\/14651858.CD003190.pub4-BIB0018|cit18","first-page":"65","article-title":"Relief of bladder spasm by Flavoxate. A comparative study","volume":"10","author":"Bradley","year":"1970","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF01907071","article-title":"Anticholinergic medication for the unstable bladder: Prospective trials of imipramine\/propantheline versus penthienate and oxybutinin versus penthienate","volume":"7","author":"Clarke","year":"1996","journal-title":"International Urogynecology Journal of Pelivic Floor Dysfunction"},{"issue":"4","key":"10.1002\/14651858.CD003190.pub4-BIB0020|cit20","first-page":"340","article-title":"Intravesical administration of drugs in patients with detrusor hyperactivity","volume":"9","author":"Ekstrom","year":"1990","journal-title":"Neurourology and Urodynamics"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0021|cit21","first-page":"86","article-title":"Management of noctural incontinence in orthotopic ileal reservoirs using oxybutinin versus verapamil: A proscpective randomised crossover study","volume":"167","author":"Bahnasawy","year":"2002","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1471-0528.1984.tb04767.x","article-title":"Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride","volume":"91(3)","author":"Gruneberger","year":"1984","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0023|cit23","first-page":"345","article-title":"Randomized double blind study to compare clinical efficacy of temeverine and propiverine for unstable bladder and detrusor hyperreflexia","volume":"16(5)","author":"Homma","year":"1997","journal-title":"Neurourology and Urodynamics"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/01.ju.0000173630.94559.fd","article-title":"Combination treatment with propiveriene hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective randomised controlled multicentre study","volume":"174","author":"Lee","year":"1005","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0025|cit25","unstructured":"Lee KS Kim DY Kim JC Kim HJ Min KS Park WH Combination treatment with propiverine hydrochloride and doxazosin GITS in men with overactive bladder coexisting benign prostatic obstruction: a prospective, randomized, controlled, multicentre study (ABSTRACT) Proceedings from the International Continence Society (34th Annual Meeting) and the International Urogynaecological Association; 2004 Aug 23-27; Paris 2004"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0026|cit26","first-page":"121","article-title":"A controlled, double blind, cross over study of terodiline in motor urge incontinence","volume":"76(2)","author":"Lukkarinen","year":"1987","journal-title":"Annales Chirurgiae et Gynaecologiae"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1464-410X.1983.tb03325.x","article-title":"Emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence associated with detrusor instability in elderly women","volume":"55(4)","author":"Robinson","year":"1983","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0028|cit28","first-page":"55","article-title":"A symptomatic and cystomtric comparison of terodiline with emepronium in the treatment of women with frequency, urgency and incontinence","volume":"87","author":"Sole","year":"1984","journal-title":"Scandanavian Journal of Urology and Nephrology Supplementum"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0029|cit29","first-page":"334","article-title":"Short term efficacy and safety of temeverine in the treatment of bladder overactivity. A randomized clinical trial in man and women","volume":"18(4)","author":"Tammela","year":"2000","journal-title":"Nerourology and Urodynamics"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00326777","article-title":"Conservative therapy of urgency and urge incontinence: a double blind clinical trial of flavoxate hydrochloride, oxybutinin chloride, emepronium bromide and placebo","volume":"5(1)","author":"Zeegers","year":"1987","journal-title":"World Journal of Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0031|cit31","unstructured":"Leistershire MRC Incontinence Study Ongoing study 1999"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0032|cit32","first-page":"481","volume-title":"Incontinence: 2nd International Consultation for Incontinence","author":"Abrams","year":"2001"},{"issue":"5","key":"10.1002\/14651858.CD003190.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/nau.1930070502","article-title":"Standardisation of terminology of lower urinary tract function","volume":"7","author":"Abrams","year":"1988","journal-title":"Neurourology & Urodynamics"},{"issue":"2","key":"10.1002\/14651858.CD003190.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurology & Urodynamics"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/01.ju.0000084623.65480.f8","article-title":"Tamsulosin: Efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury","volume":"170","author":"Abrams","year":"2003","journal-title":"Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD003190.pub4-BIB0036|cit36","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003193.pub3","article-title":"Anticholinergic drugs versus non-drug therapies for overactive bladder syndrome in adults","author":"Alhasso","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0090-4295(99)00495-1","article-title":"Treatment of overactive bladder: other drug mechanisms","volume":"55 (Suppl 5A)","author":"Andersson","year":"2000","journal-title":"Urology"},{"issue":"4","key":"10.1002\/14651858.CD003190.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1569-9056(02)00045-3","article-title":"Potential benefits of Muscarinic M3 receptor selectivity","volume":"1","author":"Andersson","year":"2002","journal-title":"European Urology Supplements"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Berghmans B Bo K Hendriks E van Kempen M die Bie R Electrical stimulation with non-implanted electrodes for urinary incontinence in adults Cochrane Database of Systematic Reviews 2004, Issue 3","DOI":"10.1002\/14651858.CD001202.pub2"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ageing\/15.5.299","article-title":"Double-blind study of imipramine and placebo for incontinence due to bladder instability","volume":"15","author":"Castleden","year":"1986","journal-title":"Age Ageing"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1464-410X.1990.tb14994.x","article-title":"Double-blind, placebo-controlled, crossover study of flavoxate in the treatment of idiopathic detrusor instability","volume":"66","author":"Chapple","year":"1990","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(05)63330-2","article-title":"Suppression of bladder hyperreflexia by intravesical instillation of resiniferatoxin","volume":"350","author":"Cruz","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000282787","article-title":"Flavoxate treatment of micturiton disorders accompanying benign prostatic hypertrophy: a double-blind, placebo-controlled, multicentre investigation","volume":"55","author":"Dahm","year":"1995","journal-title":"Urology International"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0090-4295(97)00587-6","article-title":"A neurologic basis for the overactive bladder","volume":"50 (6A Suppl)","author":"Groat","year":"1997","journal-title":"Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1464-410X.2007.06575.x","article-title":"Botulinum toxin A in the overactive bladder: current status and future directions","volume":"99(2)","author":"Dmochowski","year":"2007","journal-title":"BJU International"},{"issue":"3","key":"10.1002\/14651858.CD003190.pub4-BIB0046|cit46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005493.pub2","article-title":"Botulinum toxin injections for adults with overactive bladder syndrome","author":"Duthie","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0022-5347(01)66936-2","article-title":"Alpha blockade in the treatment of syptomatic benign prostatic hyperplasia","volume":"154","author":"Eri","year":"1995","journal-title":"Journal of Urology"},{"issue":"3","key":"10.1002\/14651858.CD003190.pub4-BIB0048|cit48","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005429","article-title":"Which anticholinergic drug for overactive bladder symptoms in adults","author":"Hay-Smith","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003190.pub4-BIB0049|cit49","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004202","article-title":"Neuromodulation with implanted electrodes for urinary storage and voiding dysfunction in adults","author":"Herbison","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0050|cit50","volume-title":"Cochrane Handbook of Systematic Reviews of Interventions (Updated Sept 2006)","volume":"4.2.6","author":"Higgins","year":"2006"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0090-4295(03)00009-8","article-title":"Estimated economic costs of overactive bladder in the United States","volume":"61","author":"Hu","year":"2003","journal-title":"Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s002400100175","article-title":"Clinical options for imipramine in management of urinary incontinence","volume":"29","author":"Hunsballe","year":"2001","journal-title":"Urological Research"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0053|cit53","first-page":"2153","article-title":"Assessment and treatment of urinary incontinence. Scientific Commitee of the First International Consultation on Incontinence","volume":"355(9221)","author":"Anonymous","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1471-0528.1997.tb11006.x","article-title":"A new questionnaire to access the quality of life of urinary incontinent women","volume":"104","author":"Kelleher","year":"1997","journal-title":"British Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0090-4295(97)00602-X","article-title":"Economic considerations and outcome measurement in urge incontinence","volume":"50(6A suppl)","author":"Kobelt","year":"1997","journal-title":"Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0022-5347(01)68164-3","article-title":"Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor","volume":"158","author":"Lazzeri","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0022-5347(17)40635-5","article-title":"Effects of intravesical instillation of verapamil in patients with detrusor hyperactivity","volume":"141","author":"Mattiasson","year":"1989","journal-title":"Journal of Urology"},{"issue":"9","key":"10.1002\/14651858.CD003190.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU International"},{"issue":"4","key":"10.1002\/14651858.CD003190.pub4-BIB0059|cit59","article-title":"Anticholinergic drugs versus placebo for overactive bladder syndrome in adults","author":"Nabi","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD003190.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/jama.1982.03330100032026","article-title":"Urinary incontinence in elderly nursing home patients","volume":"248","author":"Ouslander","year":"1982","journal-title":"Journal of the American Medical Association"},{"issue":"7","key":"10.1002\/14651858.CD003190.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1532-5415.1986.tb04242.x","article-title":"Genitourinary dysfunction in a geriatric outpatient population","volume":"34","author":"Ouslander","year":"1986","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0062|cit62","first-page":"403","article-title":"Prevalence and impact of overactive bladder in the United States: Results from the NOBLE program","volume":"20","author":"Stewart","year":"2001","journal-title":"Neurology & Urodynamics"},{"issue":"6","key":"10.1002\/14651858.CD003190.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World Journal of Urology"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-5347(17)38459-8","article-title":"Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo","volume":"145","author":"Thuroff","year":"1991","journal-title":"Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD003190.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/(SICI)1520-6777(1998)17:5<499::AID-NAU6>3.0.CO;2-8","article-title":"Dose-ranging study of tolterodine in patients with detrusor hyperreflexia","volume":"17","author":"Kerrebroeck","year":"1998","journal-title":"Neurourlogy & Urodynamics"},{"issue":"1","key":"10.1002\/14651858.CD003190.pub4-BIB0066|cit66","article-title":"Bladder training for urinary incontinence in adults","author":"Wallace","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003190.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/13543784.10.1.65","article-title":"Pharmacological agents for the treatment of urinary incontinence due to overactive bladder","volume":"10","author":"Wein","year":"2001","journal-title":"Expert Opinion on Investigational Drugs"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003190.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:02:39Z","timestamp":1754265759000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003190.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Incontinence Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,10,17]]},"references-count":67,"aliases":["10.1002\/14651858.cd003190.pub3"],"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003190.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,17]]}}}